These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5005285)

  • 1. Characteristics of complement-dependent release of phospholipid from Escherichia coli.
    Wilson LA; Spitznagel JK
    Infect Immun; 1971 Jul; 4(1):23-8. PubMed ID: 5005285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems.
    Wilson LA; Spitznagel JK
    J Bacteriol; 1968 Oct; 96(4):1339-48. PubMed ID: 4879562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethylenediaminetetraacetic acid, Triton X-100, and lysozyme on the morphology and chemical composition of isolate cell walls of Escherichia coli.
    Schnaitman CA
    J Bacteriol; 1971 Oct; 108(1):553-63. PubMed ID: 5001205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli.
    Inoue K; Kinoshita T; Okada M; Akiyama Y
    J Immunol; 1977 Jul; 119(1):65-72. PubMed ID: 326965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turnover of phospholipids in an unsaturated fatty acid auxotroph of Escherichia coli.
    Crowfoot PD; Oka T; Esfahani M; Wakil SJ
    J Bacteriol; 1972 Dec; 112(3):1396-407. PubMed ID: 4629658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. 3. Isolation of a gammag normal antibody and characterization of other serum factors causing P32 loss.
    Spitznagel JK
    J Bacteriol; 1966 Jan; 91(1):401-8. PubMed ID: 4159313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transformation of bacterial phospholipids following the action of complement].
    Barbu E; Lux M
    C R Acad Hebd Seances Acad Sci D; 1969 Jan; 268(2):449-52. PubMed ID: 4975511
    [No Abstract]   [Full Text] [Related]  

  • 8. Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli.
    Donaldson DM; Roberts RR; Larsen HS; Tew JG
    Infect Immun; 1974 Sep; 10(3):657-66. PubMed ID: 4609906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage T4-mediated release of envelope components from Escherichia coli.
    Loeb MR
    J Virol; 1974 Mar; 13(3):631-41. PubMed ID: 4595901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of lipopolysaccharide in Escherichia coli resistant to the permeability increase induced by ethylenediaminetetraacetate.
    Voll MJ; Leive L
    J Biol Chem; 1970 Mar; 245(5):1108-14. PubMed ID: 4984697
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical studies on damages of Escherichia coli by the immune bactericidal reaction. I. Release and degradation of phospholipids from damaged bacteria.
    Inoue K; Takamizawa A; Yano K; Amano T
    Biken J; 1974 Dec; 17(4):127-34. PubMed ID: 4619009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of lyophilized escherichia coli cells with egg-white lysozyme without ethylenediaminetetraacetic acid.
    Smékal F
    Folia Microbiol (Praha); 1973; 18(2):146-8. PubMed ID: 4196903
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation of lipopolysaccharide and fatty acid ester release to the ethylenediaminetetraacetic acid alteration of permeability in enterobacteriaceae.
    Winshell EB; Neu HC
    J Bacteriol; 1970 May; 102(2):537-9. PubMed ID: 4986763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of 14C label and complement killing of Escherichia coli.
    Wilson BM; Glynn AA
    Immunology; 1975 Mar; 28(3):391-400. PubMed ID: 1092608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sub-minimal inhibitory concentrations of EDTA on growth of Escherichia coli and the release of lipopolysaccharide.
    Pelletier C; Bourlioux P; van Heijenoort J
    FEMS Microbiol Lett; 1994 Apr; 117(2):203-6. PubMed ID: 8181724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-induced formation of spheres from cells and envelopes of Escherichia coli.
    Weinbaum G; Rich R; Fischman DA
    J Bacteriol; 1967 May; 93(5):1693-8. PubMed ID: 4960932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of phage T4 infection on phospholipid hydrolysis in Escherichia coli.
    Josslin R
    Virology; 1971 Apr; 44(1):94-100. PubMed ID: 4999127
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzymes of phospholipid metabolism: localization in the cytoplasmic and outer membrane of the cell envelope of Escherichia coli and Salmonella typhimurium.
    Bell RM; Mavis RD; Osborn MJ; Vagelos PR
    Biochim Biophys Acta; 1971 Dec; 249(2):628-35. PubMed ID: 5002558
    [No Abstract]   [Full Text] [Related]  

  • 20. Phospholipases and phospholipid turnover in Escherichia coli spheroplasts.
    Patriarca P; Beckerdite S; Elsbach P
    Biochim Biophys Acta; 1972 Apr; 260(4):593-600. PubMed ID: 4623878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.